Approvals/CIMA-AEMPS/KADCYLA 160 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Approved

STANDARD

KADCYLA 160 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Roche Registration Gmbh🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 58f4ce77a98f5766
Drug Cima Aemps Name: KADCYLA 160 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 113885002IP1
Holder Company Name: Roche Registration Gmbh
Marketing Company Name: Difarmed S.L.U.
Holder Company Detail Path: /organization/roche-registration-gmbh
Authorization Date: 2024-05-22
Dosage Form: POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 160 mg
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Roche Registration Gmbh
Company Detail Path: /organization/roche-registration-gmbh

TRASTUZUMAB EMTANSINA

20 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

May 22, 2024

Approval ID

58f4ce77a98f5766

Type

Standard